Literature DB >> 21126031

Enhanced cytokine secretion from primary macrophages due to Dectin-1 mediated uptake of CpG DNA/β-1,3-glucan complex.

Jusaku Minari1, Shinichi Mochizuki, Tsubasa Matsuzaki, Yoshiyuki Adachi, Naohito Ohno, Kazuo Sakurai.   

Abstract

Unmethylated CpG sequences (CpG DNA) can induce Th1 response and thus become a potential immunotherapeutic agent. A key step in the treatment is to transport CpG DNA to its receptor TLR9 located in the endocytosis pathway of target immune cells. For the effective transport, we prepared a novel complex from a β-1,3-glucan schizophyllan (SPG) and CpG DNA, and administered the complex to murine peritoneal macrophages that had been previously activated by thioglycollate and expressed a major β-1,3-glucan receptor Dectin-1 on the cellular surface. Flow cytometric analysis and microscopic observation showed that the complex was taken up by the macrophage through Dectin-1 mediated pathway. Indeed, ELISA demonstrated that IL-12 production was increased sigmoidally with increasing SPG/CpG DNA ratio in the complexation, and reached the maximum at the SPG-rich composition. In the present work, we describe a new approach to deliver CpG DNA to immune cells by use of a β-1,3-glucan/DNA complex.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21126031     DOI: 10.1021/bc1001196

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  5 in total

1.  DNA-polymer conjugates for immune stimulation through Toll-like receptor 9 mediated pathways.

Authors:  Eric A Levenson; Kristi L Kiick
Journal:  Acta Biomater       Date:  2013-12-06       Impact factor: 8.947

2.  A new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel disease.

Authors:  Hidetoshi Takedatsu; Keiichi Mitsuyama; Shinichi Mochizuki; Teppei Kobayashi; Kazuo Sakurai; Hiroshi Takeda; Yoshihide Fujiyama; Yoshikazu Koyama; Jun Nishihira; Michio Sata
Journal:  Mol Ther       Date:  2012-02-14       Impact factor: 11.454

3.  Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist.

Authors:  Kouji Kobiyama; Taiki Aoshi; Hirotaka Narita; Etsushi Kuroda; Masayuki Hayashi; Kohhei Tetsutani; Shohei Koyama; Shinichi Mochizuki; Kazuo Sakurai; Yuko Katakai; Yasuhiro Yasutomi; Shinobu Saijo; Yoichiro Iwakura; Shizuo Akira; Cevayir Coban; Ken J Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

Review 4.  Carbohydrate Conjugates in Vaccine Developments.

Authors:  Shuyao Lang; Xuefei Huang
Journal:  Front Chem       Date:  2020-04-15       Impact factor: 5.221

5.  Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel β-Glucan-Based Drug Delivery System Ameliorates Intestinal Inflammation.

Authors:  Hideto Sakisaka; Hidetoshi Takedatsu; Keiichi Mitsuyama; Shinichi Mochizuki; Kazuo Sakurai; Shotaro Sakisaka; Fumihito Hirai
Journal:  Int J Mol Sci       Date:  2020-01-20       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.